Apr 4 |
Allurion stock soars 85% on weight-loss product launch
|
Apr 4 |
Allurion Expands Virtual Care Suite to the United States
|
Mar 13 |
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
|
Mar 12 |
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
|
Mar 4 |
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
|
Feb 9 |
Jefferies starts Allurion at buy, cites weight-loss balloon device
|
Jan 23 |
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
|
Jan 11 |
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
|
Jan 9 |
Ozempic Users Might Experience Caloric Intake Rise Post-Discontinuation: Survey
|
Jan 2 |
Allurion’s digital platform gains traction with expanded strategic partnership
|